CMD Stock Ownership Activity
CANTEL MEDICAL CORP 13F holders
No value investing guru has made any change to the CANTEL MEDICAL CORP (CMD) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying CMD now?
According to the latest SEC filing(s) CANTEL MEDICAL CORP (CMD) has not been purchased by any super investor.
To see more about who is investing in CANTEL MEDICAL CORP (CMD), please go to the CMD ownership page.
2019 Q4
(1 result)
Reported price*: $74.78
2019 Q3
(1 result)
Reported price*: $74.78
2019 Q2
(1 result)
Reported price*: $80.66
2019 Q1
(1 result)
Reported price*: $66.93
2018 Q4
(1 result)
Reported price*: $74.48
2018 Q3
(1 result)
Reported price*: $91.94
2018 Q2
(1 result)
Reported price*: $98.38
2018 Q1
(1 result)
Reported price*: $111.36
2017 Q4
(1 result)
Reported price*: $102.92
2017 Q3
(1 result)
Reported price*: $94.09
10 of 10
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.